2024 -now Vice President, Head of Small Molecule Research @ Alexion, AstraZeneca Rare Disease
2023 -2024 Senior Vice President, Drug Discovery @
2022 -2023 Vice President, Discovery and Preclinical Sciences @
2021 -2022 Vice President, Preclinical Development @
2020 -2021 Senior Director, Small Molecule Research - Chemistry and Drug Metabolism and Pharmacokinetics @
2019 -2020 Executive Director, Medicinal Chemistry and Drug Metabolism and Pharmacokinetics @
2002 -2019 Research Scientist to Senior Director, Chemistry @
Jason Wiles Education
Harvard University
NSERC of Canada Postdoctoral Fellowship (Chemistry and Chemical Biology)
2000-2002
University of Alberta
Ph.D. (Chemistry)
1994-2000
Dalhousie University
B.S. (Honors in Chemistry)
1990-1994
Jason Wiles Skills
PowerPoint
Research
Microsoft Excel
Strategic Planning
Chemistry
Sales
Organic Chemistry
Biotechnology
Drug Design
Pharmaceutical Industry
Drug Development
Technology Transfer
Life Sciences
NMR spectroscopy
R&d
HPLC
Medicinal Chemistry
Drug Discovery
Jason Wiles Summary
Jason Wiles, based in New York, NY, US, is currently a Vice President, Head of Small Molecule Research at Alexion, AstraZeneca Rare Disease. Jason Wiles brings experience from previous roles at Avilar Therapeutics and Alexion Pharmaceuticals, Inc.. Jason Wiles holds a 2000 - 2002 NSERC of Canada Postdoctoral Fellowship in Chemistry and Chemical Biology @ Harvard University. With a robust skill set that includes PowerPoint, Research, Microsoft Excel, Strategic Planning, Chemistry and more. Jason Wiles has 1 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.